What are the recommended thiamine (vitamin B1) dosing regimens for prophylaxis and treatment of deficiency in adults, pregnant/lactating women, children, and infants?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Thiamine Dosing Recommendations

For prophylaxis in typical enteral/parenteral nutrition, provide 1.5-3 mg/day enterally or 2.5 mg/day parenterally; for emergency/ICU patients or suspected deficiency, administer 100-300 mg/day IV for 3-4 days without hesitation, followed by oral maintenance dosing. 1

Prophylactic Dosing in Nutrition Support

For patients receiving standard medical nutrition:

  • Enteral nutrition: 1.5-3 mg/day (based on 1500 kcal/day intake) 1
  • Parenteral nutrition: Minimum 2.5 mg/day 1
  • Mild depletion (low dietary intake, low blood thiamine diphosphate, but no symptoms): 10 mg/day orally for one week 1

The guideline emphasizes these amounts are based on dietary reference intakes and represent Grade A recommendations for maintaining adequate thiamine status 1.

Treatment Dosing by Clinical Scenario

Emergency/ICU Patients and Suspected Deficiency

Administer 100-300 mg/day IV for 3-4 days immediately upon admission to emergency or intensive care settings 1. This aggressive approach is justified because:

  • Thiamine has no toxicity even at high doses (100-500 mg single doses administered safely) 2
  • Deficiency may be present in >90% of critically ill patients 1
  • The IV route is most efficient given severity of potential complications 1

For ward patients with suspected reduced food intake or high alcohol consumption, the same 100-300 mg/day dosing applies, via either oral or IV route 1.

Wernicke-Korsakoff Syndrome (Established Diagnosis)

The FDA label provides clear guidance: 100 mg IV initially, followed by 50-100 mg IM daily until the patient consumes a regular, balanced diet 2.

Recent research supports higher dosing: 200-500 mg IV three times daily for 3-5 days, then oral 250-1,000 mg/day 3. Another protocol recommends 500 mg IV three times daily for 3-5 days, followed by 250 mg IV daily for an additional 3-5 days minimum 4.

Common pitfall: Wernicke's encephalopathy is severely underdiagnosed and undertreated 3. The classic triad (confusion, ataxia, ophthalmoplegia) is present in only a minority of cases. Treat empirically when suspected rather than waiting for confirmation.

"Wet" Beriberi with Cardiac Involvement

This is a medical emergency requiring slow IV administration 2. The FDA label specifies 10-20 mg IM three times daily for up to two weeks, followed by oral multivitamin with 5-10 mg thiamine daily for one month 2.

Refeeding Syndrome Prevention

Administer 100 mg thiamine in each of the first few liters of IV dextrose to patients with marginal thiamine status to prevent precipitating heart failure 2. This is critical as glucose administration increases thiamine demand and can unmask or worsen deficiency.

High-Risk Patients (Post-Bariatric Surgery, Prolonged Diuretics, Malnutrition)

Parenteral thiamine 250-500 mg/day for 3-5 days, followed by oral 250-300 mg/day 3. The guideline recommends measuring RBC or whole blood thiamine diphosphate in these populations 1.

Special Populations

Pregnancy with Severe Vomiting (Hyperemesis Gravidarum)

When vomiting precludes oral therapy: 5-10 mg IM daily 2. The energy-based requirement remains 0.1 mg/MJ (0.4 mg/1,000 kcal), same as non-pregnant adults 5.

Infants and Children

  • Infantile beriberi (mild): May respond to oral therapy
  • Infantile beriberi with collapse: 25 mg IV cautiously 2
  • For infants 7-11 months and children: Same energy-based requirements as adults (0.1 mg/MJ or 0.4 mg/1,000 kcal) 5

Critical warning: A 2003 outbreak in Israel demonstrated that thiamine-deficient formula caused severe neurological damage and death in infants 6. Treatment with 50 mg/day IM for 14 days reversed symptoms when caught early, but delayed diagnosis led to permanent sequelae. Suspect thiamine deficiency in infants with vomiting, lethargy, ophthalmoplegia, or failure to thrive.

Route of Administration

Thiamine is well absorbed orally except in alcohol-related gastritis 1. However, IV route is preferred for acute deficiency given the severity and rapid progression of symptoms 1. The risk of anaphylactic shock from parenteral thiamine is below 1 in 100,000 7, far lower than the mortality risk of untreated Wernicke's encephalopathy (approximately 20%) 7.

Intramuscular route is appropriate for outpatient settings, while IV is preferred for inpatients 4.

Key Clinical Pearls

  • No upper toxicity limit: Doses exceeding 30 mg three times daily are simply excreted in urine rather than utilized 2, but this does not cause harm
  • Treat before confirming: Do not wait for laboratory results when Wernicke's encephalopathy or severe deficiency is suspected 6
  • Measure RBC thiamine diphosphate (not serum thiamine) for accurate assessment 1
  • Duration matters: Longer exposure to deficiency correlates with worse outcomes and need for higher doses 6
  • Recent evidence suggests some protocols may recommend unnecessarily high total doses, with a single 100 mg dose potentially sufficient in some cases 8, but given the safety profile and severity of deficiency complications, erring on the side of higher dosing remains appropriate in clinical practice

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.